Announcements Trials

Browse Landscape

Phase

Phase 1/2 3 Phase 2 1 Phase 1 1

Status

Completed 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Cyclophosphamide 98 pembrolizumab 87 Gemcitabine 81 Carboplatin 63 fludarabine 62 Nivolumab 57 Cisplatin 54 Paclitaxel 51 Radiotherapy 50 Docetaxel 50 Rituximab 46 Dexamethasone 42 Lenalidomide 41 Ipilimumab 38 Azacitidine 35 Etoposide 34 Cytarabine 34 Temozolomide 32 Bevacizumab 32 Radiation 29 venetoclax 28 Bortezomib 27 Magnetic Resonance Spectroscopy 26 Irinotecan 26 atezolizumab 25 Pemetrexed 25 Oxaliplatin 24 Capecitabine 24 fludarabine phosphate 23 Filgrastim 23

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Terminated × AEG 35156 × Clear all

NCT00385775 2008-08-21

Study of XIAP Antisense for Advanced Cancers

Aegera Therapeutics

Phase 1 Terminated

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡